deCODE and Roche Diagnostics Announce Discovery of Significant Genetic Risk Factors for Heart Attack DNA-based diagnostics applying these findings may enable more targeted, individualized prevention strategies

Reykjavik, ICELAND, and Basel, SWITZERLAND, October 17, 2003 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) and Roche Diagnostics today announced a landmark discovery under their alliance to develop DNA-based diagnostic tests for common diseases. deCODE scientists have...

deCODE Announces Milestone in its Obesity Alliance with Merck

deCODE has discovered a gene with certain variations that predispose to obesity and others that predispose to thinness Reykjavik, ICELAND, September 30, 2003 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) today announced that it has achieved a milestone under its...

deCODE Locates First Gene Ever Linked to Psoriatic Arthritis

Reykjavik, ICELAND, December 13, 2002 — deCODE genetics (Nasdaq/Nasdaq Europe:DCGN) announced today that team of deCODE scientists has mapped to a small segment of chromosome 16 a gene contributing to psoriatic arthritis. This represents the first genetic factor...